| Product NDC: | 0074-3753 |
| Proprietary Name: | Tridione |
| Non Proprietary Name: | Trimethadione |
| Active Ingredient(s): | 150 mg/1 & nbsp; Trimethadione |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-3753 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA005856 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19460125 |
| Package NDC: | 0074-3753-01 |
| Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE (0074-3753-01) |
| NDC Code | 0074-3753-01 |
| Proprietary Name | Tridione |
| Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (0074-3753-01) |
| Product NDC | 0074-3753 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trimethadione |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 19460125 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | TRIMETHADIONE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |